Journal articles on the topic 'Class III β-tubulin'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Class III β-tubulin.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Jouhilahti, Eeva-Mari, Sirkku Peltonen, and Juha Peltonen. "Class III β-Tubulin Is a Component of the Mitotic Spindle in Multiple Cell Types." Journal of Histochemistry & Cytochemistry 56, no. 12 (September 2, 2008): 1113–19. http://dx.doi.org/10.1369/jhc.2008.952002.
Full textReader, Jocelyn, Amy K. Harper, Teklu Legesse, Paul N. Staats, Olga Goloubeva, Gautam G. Rao, Amy Fulton, and Dana M. Roque. "EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and Treatment." Cancers 11, no. 10 (October 18, 2019): 1590. http://dx.doi.org/10.3390/cancers11101590.
Full textLaferrière, Nicole B., and D. L. Brown. "Effects of taxol on the polymerization and posttranslational modification of class III β-tubulin in P19 embryonal carcinoma cells." Biochemistry and Cell Biology 73, no. 9-10 (September 1, 1995): 687–94. http://dx.doi.org/10.1139/o95-076.
Full textLinhartová, I., P. Dráber, E. Dráberová, and V. Viklický. "Immunological discrimination of β-tubulin isoforms in developing mouse brain. Post-translational modification of non-class-III β-tubulins." Biochemical Journal 288, no. 3 (December 15, 1992): 919–24. http://dx.doi.org/10.1042/bj2880919.
Full textGuo, Huiqin, Yu Zhao, Jiangyang Lu, and Zejian Li. "ERCC1, class III β-tubulin, p53, and RRM1-tailored selection of personalized chemotherapy for stage IV NSCLC patients: A prospective study." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e18087-e18087. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e18087.
Full textZhang, Shucai, Qi Li, Quan Zhang, Jinghui Wang, Haiqing Zhang, Zongde Zhang, Qunhui Wang, Xinjie Yang, Yanfei Gu, and Hui Zhang. "Expression of ERCC1 and Class III β-Tubulin in Resected Non-Small Cell Lung Cancer and its Correlation with Platinum-Based Adjuvant Chemotherapy." International Journal of Biological Markers 25, no. 3 (July 2010): 141–49. http://dx.doi.org/10.1177/172460081002500304.
Full textMariani, Marisa, Roshan Karki, Manuela Spennato, Deep Pandya, Shiquan He, Mirko Andreoli, Paul Fiedler, and Cristiano Ferlini. "Class III β-tubulin in normal and cancer tissues." Gene 563, no. 2 (June 2015): 109–14. http://dx.doi.org/10.1016/j.gene.2015.03.061.
Full textKatsetos, Christos D., Mary M. Herman, and Sverre J. Mörk. "Class III β-tubulin in human development and cancer." Cell Motility and the Cytoskeleton 55, no. 2 (April 24, 2003): 77–96. http://dx.doi.org/10.1002/cm.10116.
Full textAlfano, Alan, Jin Xu, Xi Yang, Dhanraj Deshmukh, and Yun Qiu. "SRC Kinase-Mediated Tyrosine Phosphorylation of TUBB3 Regulates Its Stability and Mitotic Spindle Dynamics in Prostate Cancer Cells." Pharmaceutics 14, no. 5 (April 25, 2022): 932. http://dx.doi.org/10.3390/pharmaceutics14050932.
Full textAlfano, Alan, Jin Xu, Xi Yang, Dhanraj Deshmukh, and Yun Qiu. "SRC Kinase-Mediated Tyrosine Phosphorylation of TUBB3 Regulates Its Stability and Mitotic Spindle Dynamics in Prostate Cancer Cells." Pharmaceutics 14, no. 5 (April 25, 2022): 932. http://dx.doi.org/10.3390/pharmaceutics14050932.
Full textCicchillitti, Lucia, Roberta Penci, Michela Di Michele, Flavia Filippetti, Domenico Rotilio, Maria Benedetta Donati, Giovanni Scambia, and Cristiano Ferlini. "Proteomic characterization of cytoskeletal and mitochondrial class III β-tubulin." Molecular Cancer Therapeutics 7, no. 7 (July 2008): 2070–79. http://dx.doi.org/10.1158/1535-7163.mct-07-2370.
Full textSève, Pascal, and Charles Dumontet. "Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?" Lancet Oncology 9, no. 2 (February 2008): 168–75. http://dx.doi.org/10.1016/s1470-2045(08)70029-9.
Full textDon, Sima, Nicole M. Verrills, Tracy Y. E. Liaw, Marjorie L. M. Liu, Murray D. Norris, Michelle Haber, and Maria Kavallaris. "Neuronal-associated microtubule proteins class III β-tubulin and MAP2c in neuroblastoma: Role in resistance to microtubule-targeted drugs." Molecular Cancer Therapeutics 3, no. 9 (September 1, 2004): 1137–46. http://dx.doi.org/10.1158/1535-7163.1137.3.9.
Full textNamal, Esat, Mustafa Bozkurt, Akin Ozturk, Kezban Nur Planci, Nuray Bassullu, Ozgul Pamukcu, Gulen Bulbul Dogusoy, Sezer Saglam, Zafer Akcali, and Gokhan Demir. "Biologic markers guiding the treatment of non-small cell lung cancer: RRM-1, class III ß tubulin, and ERCC-1." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e19127-e19127. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e19127.
Full textKatsetos, Christos D., Eduarda Dráberová, Agustin Legido, Charles Dumontet, and Pavel Dráber. "Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III β-tubulin." Journal of Cellular Physiology 221, no. 3 (July 31, 2009): 505–13. http://dx.doi.org/10.1002/jcp.21870.
Full textKatsetos, Christos D., Luis Del Valle, Jennian F. Geddes, Martha Assimakopoulou, Agustin Legido, James C. Boyd, Brian Balin, et al. "Aberrant Localization of the Neuronal Class III β-Tubulin in Astrocytomas." Archives of Pathology & Laboratory Medicine 125, no. 5 (May 1, 2001): 613–24. http://dx.doi.org/10.5858/2001-125-0613-alotnc.
Full textKatsetos, Christos D., George Kontogeorgos, Jennian F. Geddes, Mary M. Herman, Hera Tsimara-Papastamatiou, Yunxia Yu, Lazaros I. Sakkas, et al. "Differential Distribution of the Neuron-Associated Class III β-Tubulin in Neuroendocrine Lung Tumors." Archives of Pathology & Laboratory Medicine 124, no. 4 (April 1, 2000): 535–44. http://dx.doi.org/10.5858/2000-124-0535-ddotna.
Full textKarkavelas, George, Christos D. Katsetos, Jennian F. Geddes, Mary M. Herman, Stanley A. Vinores, Harry S. Cooper, Javier Provencio, and Anthony Frankfurter. "Class III β-Tubulin isotype (β III) in the adrenal medulla: II. Localization in primary human pheochromocytomas." Anatomical Record 250, no. 3 (March 1998): 344–50. http://dx.doi.org/10.1002/(sici)1097-0185(199803)250:3<344::aid-ar9>3.0.co;2-#.
Full textSharma, Rajesh K., and Peter A. Netland. "Early born lineage of retinal neurons express class III β-tubulin isotype." Brain Research 1176 (October 2007): 11–17. http://dx.doi.org/10.1016/j.brainres.2007.07.090.
Full textŠkoda, D., K. Kranda, M. Bojar, L. Glosová, J. Bäurle, J. Kenney, D. Romportl, M. Pelichovská, and K. Cvachovec. "Antibody formation against β-tubulin class III in response to brain trauma." Brain Research Bulletin 68, no. 4 (January 2006): 213–16. http://dx.doi.org/10.1016/j.brainresbull.2005.05.032.
Full textPOWELL, STEVEN, ALEX KAIZER, JOSEPH S. KOOPMEINERS, CARLOS IWAMOTO, and MARK KLEIN. "High expression of class III β-tubulin in small cell lung carcinoma." Oncology Letters 7, no. 2 (December 6, 2013): 405–10. http://dx.doi.org/10.3892/ol.2013.1734.
Full textGiordana, M. T., P. Cavalla, A. Dutto, and D. Schiffer. "CLASS III β-TUBULIN AND CALBINDIN IN MEDULLOBLASTOMA OF CHILDREN AND ADULTS." Journal of Neuropathology and Experimental Neurology 55, no. 5 (May 1996): 625. http://dx.doi.org/10.1097/00005072-199605000-00093.
Full textLiu, Li, Eldon E. Geisert, Anthony Frankfurter, Anthony J. Spano, Chloe Xue Jiang, Junming Yue, Ioannis Dragatsis, and Dan Goldowitz. "A transgenic mouse Class-III β tubulin reporter using yellow fluorescent protein." genesis 45, no. 9 (September 2007): 560–69. http://dx.doi.org/10.1002/dvg.20325.
Full textLocher, Heiko, Karien E. de Rooij, John C. M. J. de Groot, Remco van Doorn, Nelleke A. Gruis, Clemens W. G. M. Löwik, Susana M. Chuva de Sousa Lopes, Johan H. M. Frijns, and Margriet A. Huisman. "Class III β-tubulin, a novel biomarker in the human melanocyte lineage." Differentiation 85, no. 4-5 (April 2013): 173–81. http://dx.doi.org/10.1016/j.diff.2013.05.003.
Full textWoulfe, J. "Class III β-tubulin immunoreactive intranuclear inclusions in human ependymomas and gangliogliomas." Acta Neuropathologica 100, no. 4 (October 28, 2000): 427–34. http://dx.doi.org/10.1007/s004010000191.
Full textLocher, H., N. Saadah, S. de Groot, J. C. M. J. de Groot, J. H. M. Frijns, and M. A. Huisman. "Hair follicle bulge cultures yield class III β-tubulin-positive melanoglial cells." Histochemistry and Cell Biology 144, no. 1 (February 28, 2015): 87–91. http://dx.doi.org/10.1007/s00418-015-1312-8.
Full textKatsetos, Christos D., Eduarda Dráberová, Barbora Šmejkalová, Goutham Reddy, Louise Bertrand, Jean-Pierre de Chadarévian, Agustin Legido, Jonathan Nissanov, Peter W. Baas, and Pavel Dráber. "Class III β-Tubulin and γ-Tubulin are Co-expressed and Form Complexes in Human Glioblastoma Cells." Neurochemical Research 32, no. 8 (April 4, 2007): 1387–98. http://dx.doi.org/10.1007/s11064-007-9321-1.
Full textKatsetos, Christos D., George Karkavelas, Mary M. Herman, Stanley A. Vinores, Javier Provencio, Anthony J. Spano, and Anthony Frankfurter. "Class III β-Tubulin isotype (β III) in the adrenal medulla: I. Localization in the developing human adrenal medulla." Anatomical Record 250, no. 3 (March 1998): 335–43. http://dx.doi.org/10.1002/(sici)1097-0185(199803)250:3<335::aid-ar8>3.0.co;2-z.
Full textGanguly, Anutosh, Hailing Yang, and Fernando Cabral. "Class III β-Tubulin Counteracts the Ability of Paclitaxel to Inhibit Cell Migration." Oncotarget 2, no. 5 (May 16, 2011): 368–77. http://dx.doi.org/10.18632/oncotarget.250.
Full textOshima, Shohei, and Yasutaka Yawaka. "Class III β-tubulin expression during hard tissue formation in developing mouse teeth." Pediatric Dental Journal 30, no. 1 (April 2020): 9–16. http://dx.doi.org/10.1016/j.pdj.2019.12.002.
Full textStapor, Peter C., and Walter L. Murfee. "Identification of class III β-tubulin as a marker of angiogenic perivascular cells." Microvascular Research 83, no. 2 (March 2012): 257–62. http://dx.doi.org/10.1016/j.mvr.2011.09.003.
Full textKang, Jun, and Inchul Lee. "TuJ1 (class III β-tubulin) as phenotypic marker of lymphatic and venous valves." Cardiovascular Pathology 15, no. 4 (July 2006): 218–21. http://dx.doi.org/10.1016/j.carpath.2006.04.001.
Full textTerry, S., G. Ploussard, Y. Allory, N. Nicolaiew, F. Boissière-Michot, P. Maillé, L. Kheuang, et al. "Increased expression of class III β-tubulin in castration-resistant human prostate cancer." British Journal of Cancer 101, no. 6 (August 18, 2009): 951–56. http://dx.doi.org/10.1038/sj.bjc.6605245.
Full textStengel, C., S. P. Newman, M. P. Leese, B. V. L. Potter, M. J. Reed, and A. Purohit. "Class III β-tubulin expression and in vitro resistance to microtubule targeting agents." British Journal of Cancer 102, no. 2 (December 22, 2009): 316–24. http://dx.doi.org/10.1038/sj.bjc.6605489.
Full textKavallaris, M., C. A. Burkhart, and S. B. Horwitz. "Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol." British Journal of Cancer 80, no. 7 (May 7, 1999): 1020–25. http://dx.doi.org/10.1038/sj.bjc.6690507.
Full textFerreira, Adriana, and A. Caceres. "Expression of the Class III β-tubulin isotype in developing neurons in culture." Journal of Neuroscience Research 32, no. 4 (August 1992): 516–29. http://dx.doi.org/10.1002/jnr.490320407.
Full textAltonsy, Mohammed O., Anutosh Ganguly, Matthias Amrein, Philip Surmanowicz, Shu Shun Li, Gilles J. Lauzon, and P. Régine Mydlarski. "Beta3-Tubulin Is Critical for Microtubule Dynamics, Cell Cycle Regulation, and Spontaneous Release of Microvesicles in Human Malignant Melanoma Cells (A375)." International Journal of Molecular Sciences 21, no. 5 (February 28, 2020): 1656. http://dx.doi.org/10.3390/ijms21051656.
Full textGuo, Huiqin, Yu Zhao, Jiangyang Lu, David C. Christiani, Xihong Lin, and Zhaoxi Wang. "Extensive surgical resection in stage IV non-small cell lung cancer patients after tailored chemotherapy." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e19080-e19080. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e19080.
Full textPêknicová, Jana, Alena Kubátová, Vadym Sulimenko, Eduarda Dráberová, Vladimír Viklický, Pavel Hozák, and Pavel Dráber. "Differential Subcellular Distribution of Tubulin Epitopes in Boar Spermatozoa: Recognition of Class III β-Tubulin Epitope in Sperm Tail1." Biology of Reproduction 65, no. 3 (September 1, 2001): 672–79. http://dx.doi.org/10.1095/biolreprod65.3.672.
Full textMartinelli, Enrica, Andrea Fattorossi, Alessandra Battaglia, Marco Petrillo, Giuseppina Raspaglio, Gian Franco Zannoni, Mara Fanelli, Daniela Gallo, and Giovanni Scambia. "Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer." Translational Oncology 11, no. 2 (April 2018): 358–65. http://dx.doi.org/10.1016/j.tranon.2018.01.016.
Full textYahiro, Kenichiro, Yoshihiro Matsumoto, Jun-ichi Fukushi, Ken-ichi Kawaguchi, Makoto Endo, Nokitaka Setsu, Keiichiro IIda, et al. "Class III β-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell Line." Analytical Cellular Pathology 2018 (June 21, 2018): 1–11. http://dx.doi.org/10.1155/2018/8987568.
Full textLinhartová, Irena, Eduarda Dráberová, Vladimír Viklický, and Pavel Dráber. "Distribution of non-class-III β-tubulin isoforms in neuronal and non-neuronal cells." FEBS Letters 320, no. 1 (March 29, 1993): 79–82. http://dx.doi.org/10.1016/0014-5793(93)81662-j.
Full textDe Donato, Marta, Marisa Mariani, Lella Petrella, Enrica Martinelli, Gian Franco Zannoni, Valerio Vellone, Gabriella Ferrandina, Shohreh Shahabi, Giovanni Scambia, and Cristiano Ferlini. "Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer." Journal of Cellular Physiology 227, no. 3 (December 22, 2011): 1034–41. http://dx.doi.org/10.1002/jcp.22813.
Full textZhao, Xiaoli, Changli Yue, Jiamin Chen, Cheng Tian, Dongmei Yang, Li Xing, Honggang Liu, and Yulan Jin. "Class III β-Tubulin in Colorectal Cancer: Tissue Distribution and Clinical Analysis of Chinese Patients." Medical Science Monitor 22 (October 23, 2016): 3915–24. http://dx.doi.org/10.12659/msm.901252.
Full textGan, Pei Pei, Eddy Pasquier, and Maria Kavallaris. "Class III β-Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non–Small Cell Lung Cancer." Cancer Research 67, no. 19 (October 1, 2007): 9356–63. http://dx.doi.org/10.1158/0008-5472.can-07-0509.
Full textHisaoka, Masanori, Sumika Okamoto, Shune Koyama, Tsuyoshi Ishida, Tetsuo Imamura, Hiroaki Kanda, Toru Kameya, Jeanne M. Meis-Kindblom, Lars-Gunnar Kindblom, and Hiroshi Hashimoto. "Microtubule-Associated Protein-2 and Class III β-Tubulin Are Expressed in Extraskeletal Myxoid Chondrosarcoma." Modern Pathology 16, no. 5 (May 2003): 453–59. http://dx.doi.org/10.1097/01.mp.0000067422.61241.64.
Full textMhaidat, Nizar M., Rick F. Thorne, Charles Edo de Bock, Xu Dong Zhang, and Peter Hersey. "Melanoma cell sensitivity to Docetaxel-induced apoptosis is determined by class III β-tubulin levels." FEBS Letters 582, no. 2 (December 18, 2007): 267–72. http://dx.doi.org/10.1016/j.febslet.2007.12.014.
Full textYang, Liang, Zhi-Fei Wang, Hao Wu, and Wei Wang. "miR-142-5p Improves Neural Differentiation and Proliferation of Adipose-Derived Stem Cells." Cellular Physiology and Biochemistry 50, no. 6 (2018): 2097–107. http://dx.doi.org/10.1159/000495054.
Full textMartinez-Diaz, Hilda, B. K. Kleinschmidt-DeMasters, Suzanne Z. Powell, and Anthony T. Yachnis. "Giant Cell Glioblastoma and Pleomorphic Xanthoastrocytoma Show Different Immunohistochemical Profiles for Neuronal Antigens and p53 but Share Reactivity for Class III β-Tubulin." Archives of Pathology & Laboratory Medicine 127, no. 9 (September 1, 2003): 1187–91. http://dx.doi.org/10.5858/2003-127-1187-gcgapx.
Full textÖZTOP, SIDIKA, AYNUR IŞIK, GÜNEŞ GÜNER, HAKAN GÜRDAL, ERDEM KARABULUT, ERKAN YILMAZ, and AYTEKİN AKYOL. "Class III β-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response." Anticancer Research 39, no. 2 (February 2019): 655–62. http://dx.doi.org/10.21873/anticanres.13160.
Full text